Gemcitabine
![]() |
- ₹8600
- Product name: Gemcitabine
- CAS: 95058-81-4
- MF: C9H11F2N3O4
- MW: 263.2
- EINECS:619-100-6
- MDL Number:MFCD00869720
- Synonyms:2'-Deoxy-2',2'-difluoro-D-cytidine;2''-DEOXY-2'',2''-DIFLUOROCYTIDINE(GEMCITABINE);2',2'-Difluorodeoxycytidine;Cytidine, 2'-deoxy-2',2'-difluoro-;NSC 613327;gencitabine base;2'-Deoxy-2',2'-difluro cytidine Hydrochloride;GEMCITABINE (2''-DEOXY-2'', 2''-DIFLUOROCYTIDINE)
1 prices
Selected condition:
Brand
- TCI Chemicals (India)
Package
- 1G
- ManufacturerTCI Chemicals (India)
- Product numberG0544
- Product descriptionGemcitabine
- Packaging1G
- Price₹8600
- Updated2022-05-26
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
TCI Chemicals (India) | G0544 | Gemcitabine | 1G | ₹8600 | 2022-05-26 | Buy |
Properties
Melting point :168,64 C
alpha :365 +425.36°; D +71.51°
Boiling point :482.7±55.0 °C(Predicted)
Density :1.84±0.1 g/cm3(Predicted)
storage temp. :Keep in dark place,Sealed in dry,Store in freezer, under -20°C
solubility :Methanol (Slightly), Water (Slightly, Heated)
pka :11.65±0.70(Predicted)
form :Solid
color :White to Off-White
CAS DataBase Reference :95058-81-4(CAS DataBase Reference)
alpha :365 +425.36°; D +71.51°
Boiling point :482.7±55.0 °C(Predicted)
Density :1.84±0.1 g/cm3(Predicted)
storage temp. :Keep in dark place,Sealed in dry,Store in freezer, under -20°C
solubility :Methanol (Slightly), Water (Slightly, Heated)
pka :11.65±0.70(Predicted)
form :Solid
color :White to Off-White
CAS DataBase Reference :95058-81-4(CAS DataBase Reference)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Gemcitabine (2’,2’-difluorodeoxycytidine; dFdCyd) is a novel deoxycytidine analogue with both structural and metabolic similarities to cytarabine. It has a broad spectrum of antitumor activity in preclinical murine leukemia and solid tumor models. This drug requires intracellular phosphorylation that results in the accumulation of difluorodeoxycytidine triphosphate (dFdCTP). The dFdCTP competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA, which in turn inhibits DNA synthesis and terminates DNA chain elongation. In addition, this drug reduces intracellular deoxynucleoside triphosphate pools, presumably through the inhibition of ribonucleotide reductase.Gemcitabine is used alone or with other treatments/medications to treat certain types of cancer (including breast cancer, non-small cell lung cancer, ovarian cancer, pancreatic cancer, bladder cancer, bone cancer, Ewing’s sarcoma, mesenchymal chondrosarcoma osteosarcoma, dedifferentiated chondrosarcoma, head and neck cancers-cancer of the nasopharynx, hepatobiliary cancers including gallbladder cancer, Hodgkin lymphoma, kidney cancer, malignant pleural mesothelioma, non Hodgkin lymphoma, non-melanoma skin cancer – dermatofibrosarcoma protuberans (DFSP), occult primary, small cell lung cancer, soft tissue sarcoma, testicular cancer, thymic malignancies, uterine malignancies). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells. One commercial product of gemcitabine is Gemzar, which is supplied in a sterile form for intravenous use only.
Related product price
- 126-11-4
₹1800-7700 - Glycine
₹280-116823.4 - 1,4-Dioxane
₹610-668130